[A clinicobacteriologic study on sultamicillin fine granules in pediatric sinusitis]. 1994

R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
Sugita Otorhinolaryngologic Clinic.

We carried out clinical and bacteriological studies on sultamicillin (SBTPC) in pediatric sinusitis at 10 general practice settings. The results are summarized as follows. 1. The major isolated organisms from purulent nasal discharges were Streptococcus pneumoniae 27.5%, Haemophilus influenzae 32.4% and Moraxella catarrhalis 9.9%. Similar results were observed for the major isolates from nasopharynx. 2. 33% of the isolated S. pneumoniae were penicillin-insensitive S. pneumoniae (PISP) against which the MICs were equal to or higher than 0.1 microgram/ml. 3. PISP was isolated from 14% of all cases. 4. The clinical efficacy rate was 77.5% and was deemed satisfactory. 5. In the bacteriological study, persistence rate of PISP was 38.5% among the PISP from purulent nasal discharge and 60.0% among the PISP from nasopharynx which and these values were significantly higher than persistence rates of PSSP, H. influenzae and M. catarrhalis. 6. Adverse reactions were observed in 21.5% of all cases, involving diarrhea and loose stool.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D012852 Sinusitis Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES. Sinus Infections,Infection, Sinus,Infections, Sinus,Sinus Infection,Sinusitides

Related Publications

R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
R Sugita, and K Deguchi, and Y Fujimaki, and S Asai, and K Okano, and N Komatsu, and K Shimizu, and S Saito, and H Watanabe, and M Naito
December 1988, The Japanese journal of antibiotics,
Copied contents to your clipboard!